NCT05305430
Recruiting
Not Applicable
A Multi-Center Post-Market Data Collection Protocol to Evaluate the Performance of Synergy Spine Solutions Synergy Disc
Synergy Spine Solutions3 sites in 1 country200 target enrollmentMay 1, 2022
ConditionsCervical Disc Degeneration
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cervical Disc Degeneration
- Sponsor
- Synergy Spine Solutions
- Enrollment
- 200
- Locations
- 3
- Primary Endpoint
- Neck Disability Index
- Status
- Recruiting
- Last Updated
- 5 months ago
Overview
Brief Summary
This trial is a real world data (RWD) collection observational study, comprised of both prospective and retrospective arms, that will examine the safety and effectiveness of the Synergy Cervical Disc System in patients with degenerative cervical disc disease.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Over the age of 21 at the time of the surgery.
- •Have had (retrospective cohort) or the decision has been made to have (prospective cohort) the Synergy Disc implanted
- •Skeletally mature patients for reconstruction of the disc from C3-C7 following a single or multiple level discectomy for intractable radiculopathy
- •Intractable radiculopathy and/or myelopathy with at least one of the following producing symptomatic nerve root and/or spinal cord compression: herniated disc and/or osteophyte formation
- •Symptomatic nerve root and/or spinal cord compression documented by patient history (arm or neck pain and/or neurologic deficit) and imaging (CT, MRI, x-rays, etc.)
- •Failed a minimum of 6 weeks conservative treatment
- •Written informed consent given by subject, as applicable.
Exclusion Criteria
- •Moderate to advanced spondylosis
- •Diagnosis of osteoporosis
- •Active systemic infection or infection at the operative site
- •Marked cervical instability on lateral, coronal, or flexion/extension radiographs
- •Cervical spine condition other than symptomatic cervical disc disease requiring surgical treatment at the involved level
- •Severe pathology of the facet joints of the involved vertebral bodies
- •Previous diagnosis of osteopenia or osteomalacia
- •More than one immobile vertebral level between C1 and T1 from any cause
- •Morbid obesity
- •Currently a prisoner
Outcomes
Primary Outcomes
Neck Disability Index
Time Frame: 12 months
\>15 improvement in NDI score (out of 100) in subjects by 12 mo. post operative compared with baseline
Device Related or Device Procedure Related Adverse Events
Time Frame: 12 months
Absence of major device related adverse events defined as radiographic failure, neurological failure, or failure by adverse event
Secondary Outcomes
- Patient Satisfaction(6 weeks, 3 months, 6 months, 12 months, annually post operatively)
- Nurick's Criteria(pre-operative and 6 weeks, 3 months, 6 months, 12 months, annually post operatively)
- Neurologic Function(6 weeks, 3 months, 6 months, 12 months, annually post operatively)
- Visual Analog (VAS) pain(pre-operative and 6 week, 3 months, 6 months, 12 months, annually post operatively)
- Odom's Criteria(6 weeks, 3 months, 6 months, 12 months, annually post operatively)
Study Sites (3)
Loading locations...
Similar Trials
Withdrawn
Not Applicable
Multi-Centre Post-Market Data CollectionCervical Degenerative Disc DiseaseNCT06413225Synergy Spine Solutions50
Recruiting
Not Applicable
Post-Market Data Collection to Evaluate the Performance of the Synergy Disc®Cervical Degenerative Disc DiseaseNCT06383962Synergy Spine Solutions50
Recruiting
Not Applicable
Post Market Data Collection Protocol to Evaluate the Performance of the Synergy DiscCervical Degenerative Disc DiseaseNCT05880823Synergy Spine Solutions50
Recruiting
Not Applicable
Real World Data Collection on the Synergy DiscCervical Degenerative Disc DiseaseNCT06383949Synergy Spine Solutions50
Unknown
Not Applicable
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRingDiverticulum, ColonColorectal NeoplasmsCrohn DiseaseColitis, UlcerativeColostomyIleostomy - StomaRectal ProlapseIntestinal PolyposisLymphomaEndometriosisIntestinal VolvulusNCT01880918novoGI200